Anzeige
Mehr »
Login
Montag, 23.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Die erste börsennotierte Gesellschaft, die auf das gemeinsame Wachstum von Solana, XRP und Dogecoin setzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
431 Leser
Artikel bewerten:
(2)

Smile CDR Inc.: Smile Digital Health and HealthLX Announce Partnership and Provide Two Innovative FHIR Solutions

Finanznachrichten News

Smile and HealthLX collaborate to expedite FHIR-based CMS compliance and enterprise interoperability solutions.

TORONTO, ON / ACCESSWIRE / June 1, 2023 / Smile Digital Health (Smile), a leading Fast Healthcare Interoperability Resources (FHIR®) health data fabric and exchange solutions provider, today announced a partnership with HealthLX to bring FHIR solutions to payers and providers looking to solve CMS compliance mandates and long-term enterprise interoperability needs.

Smile CDR Inc. (doing business as Smile Digital Health), Thursday, June 1, 2023, Press release picture

Pairing Smile Digital Health's HL7® FHIR standard-based Health Data Fabric (HDF) platform with the Composable Automation platform and advanced ingestion engine from HealthLX results in a powerful alternative to traditional "check-the-box" CMS mandate integration.

The first solution, CMS Mandate Acceleration, offers cost-effective compliance with CMS interoperability final and proposed rules, including CMS-9115-F, CMS-0057-P and CMS-9123-P. It is ideal for payers and providers starting their compliance efforts or those looking to replace legacy solutions or unsuccessful implementations.

The second solution, FHIR First Enterprise, offers the foundation for an FHIR-based strategy to address operational needs such as care management, administration, claims and an endless number of other use cases that benefit from repeatable design patterns and complex data orchestration.

Both solutions provide the foundational infrastructure that allows organizations to mature into a standards-focused enterprise environment at a pace that allows each organization to innovate at their own speed, building on their foundational FHIR investments.

"HealthLX has an exceptional platform that will accelerate and simplify the creation of value for our shared clients. Our combined offering, matching Smile's health data fabric and HealthLX workflow automation, is uniquely flexible. Our clients will benefit significantly from the combined offering, getting services to market quickly and sustainably," said Duncan Weatherston, Chief Executive Officer, Smile Digital Health.

"Our product focus is on the automation needs of interoperability for healthcare stakeholders and is recognized for the composable approach that our solution delivers," said Will Tesch, Chief Executive Officer, HealthLX. "Best-of-breed solutions are optimal to address the wide array of interoperability challenges in the healthcare marketplace. With our strategic alignment with Smile Digital Health, we believe combined offerings meet a market need desperate for compliance now, but built for organizations recognizing the need to adapt to a FHIR-First future."

To learn more about these new solutions provided by Smile and HealthLX, email sales@smiledigitalhealth.com and sales@healthlx.com.

About HealthLX

HealthLX (Healthcare Language Exchange) solves interoperability and data exchange challenges by providing repeatable data transformations at scale. Our Composable Automation platform gives payers and providers the flexibility to support FHIR translation with other data standards (HL7 V2, EDI, CCDA) to automate workflows whether to comply with federal regulations or create operational efficiencies through application integration. We are a founding member of Health Level Seven International's (HL7) Da Vinci Project and built several reference implementations for these CMS compliance use cases. For more information, visit HealthLX.com.

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare's digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share the health information to power digital transformation. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through the intelligent use of information, and ultimately delivering better patient outcomes. For more information, visit SmileDigitalHealth.com.

Contact Information

Victoria Valladolid
Director of Marketing, Smile Digital Health
pr@smiledigitalhealth.com
(877) 537-3343 x 728

SOURCE: Smile Digital Health

.

View source version on accesswire.com:
https://www.accesswire.com/758533/Smile-Digital-Health-and-HealthLX-Announce-Partnership-and-Provide-Two-Innovative-FHIR-Solutions

© 2023 ACCESSWIRE
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.